- 10x Genomics, Inc. is a global life sciences technology company developing innovative biological products from their cross-functional expertise across biology, chemistry, software, and hardware with a broad global customer base.
- 10x Genomics offers a variety of applications and products for customers to analyze biological systems at fundamental resolutions on massive scales covering instruments, consumables, and software.
- 10x Genomics is in a strong financial position with sufficient cash and expectations of +66% revenue growth in 2021 (2020 Revenue: $298.8M | Net loss: -$542.7M).
- In summary, the author projects 10x Genomics, Inc. as a "buy" at a 1-year price target of $204 (+16% upside).
For further details see:
10x Genomics: Promising Growth From A Life Science Leading Single Cell Specialist